Diabetes Pills
-
{
- All
- News
'Diabetes Pills' - 1 News Result(s)
-
Novo Nordisk Bets On Once-Weekly China Developed Obesity Pill In Deal Worth $2.6 Billion
The deal covers HRS-1596, a drug candidate that targets two gut hormone receptors, glucagon-like peptide-1 (GLP-1R) and gastric inhibitory polypeptide (GIPR).
'Diabetes Pills' - 1 News Result(s)
-
Novo Nordisk Bets On Once-Weekly China Developed Obesity Pill In Deal Worth $2.6 Billion
The deal covers HRS-1596, a drug candidate that targets two gut hormone receptors, glucagon-like peptide-1 (GLP-1R) and gastric inhibitory polypeptide (GIPR).
